P1.24. Spatially Defined Immune Response Signatures in 5µm Tumor Section of Resected T1-2N0M0 Lung Cancer Predict Clinical Outcome - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Ping Yang
Meta Tag
Speaker Ping Yang
Topic Pathology & Biomarkers: Prognostic Biomarkers
immune response signatures
NSCLC tumors
clinical outcomes
FFPE tumors
antitumor capability
immune system
risk of recurrence
gene expression panels
immuno biomarkers
personalized treatment decisions
Powered By